2026 North Carolina Legislative Session Summary
Victory in the fight against cancer requires bold new public policies that promote cancer prevention, early detection of cancer, and expand access to quality, affordable health care. Lawmakers make many decisions that impact the lives of North Carolinians impacted by cancer and their leadership is vital to defeating this disease. In 2026 the American Cancer Society Cancer Action Network (ACS CAN) worked with the North Carolina General Assembly on legislative and regulatory efforts that provide affordable, adequate access to health insurance including Medicaid, ensure adequate funding for lifesaving cancer screening and prevention programs, and engage in prevention policies to protect kids from tobacco products and help support those who are trying to quit. This session, we made progress in the fight against cancer by prioritizing the following policies:
Ensuring Access to Quality Care
- Access to Biomarker Testing: ACS CAN advocated for improved coverage of comprehensive biomarker testing in North Carolina. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a person’s own genes or proteins to better diagnose and treat diseases like cancer. Biomarker testing is an important step to accessing precision medicine which includes targeted therapies that can lead to improved survivorship and better quality of life for cancer patients, but insurance coverage for biomarker testing is failing to keep pace with innovations and advancements in treatment. To address this, we helped push legislation to increase access to biomarker testing on public and private health plans. The bill passed the NC House but stalled in the Senate. ACS CAN looks forward to continuing to advocate for increased biomarker testing coverage in North Carolina.
- Medicaid Defense: The preservation of eligibility, coverage, and access to Medicaid remains critically important for many low-income state residents who depend on the program for cancer and chronic disease prevention, as well as early detection, diagnostic, and treatment services. Due to new federal guidelines, North Carolina’s Medicaid program has adopted new policies which could make it more difficult for cancer patients to receive critical care and treatment provided through Medicaid coverage. ACS CAN pushed back against the new policies and will work to ensure Medicaid enrollees have adequate access and coverage and will oppose proposals that create barriers or reduce access to care for cancer patients, survivors, and those who could be diagnosed with cancer.
Cancer Prevention and Early Detection
- Breast and Cervical Cancer: ACS CAN advocated to maintain state funding of $1.6 million for North Carolina’s Breast & Cervical Cancer Control Program. We support legislation to eliminate out-of-pocket costs for breast cancer diagnostic imaging and will continue to support legislation aimed at improving coverage of diagnostic, screening, and supplemental examinations for breast and cervical cancer.
Reducing the Toll of Tobacco
- Tobacco Prevention and Cessation Funding: ACS CAN worked to maintain funding for fact-based, statewide tobacco prevention and cessation programs housed under the Department of Health and Human Services.
For more information, contact: Jon Charest, Regional Government Relations Director ACS CAN
[email protected] | 336-707-6614
ACS CAN is making cancer a top priority for public officials and candidates at the federal, state, and local levels. ACS CAN empowers advocates across the country to make their voices heard and influence evidence-based public policy changes as well as legislative and regulatory solutions that will reduce the cancer burden. As the American Cancer Society’s nonprofit, nonpartisan advocacy affiliate, ACS CAN is critical to the fight for a world without cancer. For more information, please visit www.fightcancer.org.